Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia

by Brasso C, Bellino S, Bozzatello P, Montemagni C, Rocca P
Published 2017

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase II...

by Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ
Published 2017